Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Print-HAS: Ramelteon for Insomnia in Hypertensive Patients
NCT05414864Phase 4Terminated
- Sponsor
- Universidade de São Paulo
- Start
- May 2022
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ramelteon in Insomnia, sponsored by Universidade de São Paulo. Started May 2022; status: terminated.
02
Drugs
ramelteon
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT05414864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05414864.